about
Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspectiveRole of DNA methylation in renal cell carcinomaRole of systemic chemotherapy in metastatic hormone-sensitive prostate cancerKidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeTargeting chemokine pathways in esophageal adenocarcinoma.Alterations in the ribosomal machinery in cancer and hematologic disorders.Copy number variations in urine cell free DNA as biomarkers in advanced prostate cancer.miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.Corticosteroid-resistant bulbar neurosarcoidosis responsive to intravenous immunoglobulin.Upregulation of TET activity with ascorbic acid induces epigenetic modulation of lymphoma cells.Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells.Notch Pathway Is Activated via Genetic and Epigenetic Alterations and Is a Therapeutic Target in Clear Cell Renal Cancer.Low hypoxia inducible factor-1α (HIF-1α) expression in testicular germ cell tumors - a major reason for enhanced chemosensitivity?Pembrolizumab induced bulbar myopathy and respiratory failure with necrotizing myositis of the diaphragm.Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist.Scleroderma Induced by Pembrolizumab: A Case Series.Ascorbic Acid in Cancer Treatment: Let the Phoenix FlyIs ADRM1 a Good Target for Cancer Therapy?Pembrolizumab induced severe sclerodermoid reactionAssociation Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinomaEpigenetic dysregulation by aberrant metabolism in renal cell carcinoma can be reversed with Ascorbic acidHigh-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse modelMalignant pleural mesothelioma
P50
Q26744089-2904305E-8556-4B23-9B63-D1CFB602885BQ26801268-DB560026-7DC5-40DC-B7F8-7E5367A3C532Q28076110-BA905127-F1E0-47D9-B6B6-22168659D0A0Q35582141-CBD48233-A27A-4752-81B7-878DD862CC25Q35743810-1B8A8D01-C5CB-4093-AA45-80C96139D725Q36187424-D026F8E4-7D9D-4E06-8B4A-E55EE42A80DDQ36222432-F4F457AD-148C-4980-8C76-9470AE4244C5Q37392579-9660A70C-642D-47AD-9464-B99DCCD4731FQ37408814-3AFCB7C8-6E39-49E3-850F-9AF52E04CDB6Q38455471-8A67B1F1-7B6D-43DE-B7F7-676B037F2E48Q38668222-005F7656-C020-4E44-8C00-74A7C567FF24Q38714689-64F28E04-A75A-4513-A325-0D0D20C7D8A9Q39138075-A881633A-4769-4F9D-BA6C-D6237B5BEBA4Q41662386-21003234-30D9-40F6-8DA9-ABF938B80D2AQ42023824-9E6631E3-5FF8-43EF-A542-9DC92F65448BQ42086368-CE9456F2-C22E-4325-BAF2-866DC369BD1FQ50164781-8BB1A28E-2B30-423A-ACFE-F1721B6FE5EBQ50951682-3CC5A783-0764-42B1-930F-6B17C419DE44Q57169600-A989CEDE-DD95-4747-A11E-4F9F529E8367Q87156455-D11321CC-3DD7-4E00-8DC7-CB1AB69F8AF5Q88556056-1D78C792-C652-433E-87BF-20AAE4BBD75FQ90754137-7ACBDFE0-CED0-4B99-A3FC-4C35365F2C0DQ91288731-2483F717-4CCA-4375-A4C1-8755A1F93DDBQ92309090-05D20BCA-B258-4721-A156-EFC54880BA60Q92479452-C3F93F19-40DD-40CC-B7E7-51099136A301Q95364286-B1BD1974-1CB0-46E5-8495-EAD3E4C83DC2
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2074-1108
@en
name
Niraj Shenoy
@ast
Niraj Shenoy
@en
Niraj Shenoy
@es
Niraj Shenoy
@nl
type
label
Niraj Shenoy
@ast
Niraj Shenoy
@en
Niraj Shenoy
@es
Niraj Shenoy
@nl
prefLabel
Niraj Shenoy
@ast
Niraj Shenoy
@en
Niraj Shenoy
@es
Niraj Shenoy
@nl
P106
P31
P496
0000-0003-2074-1108